Abstract:MicroRNAs (miRNAs) regulate gene expression posttranscriptionally and are implicated in viral replication and host tropism. miRNAs can impact the viruses either by directly interacting with the viral genome or modulating host factors. Although many miRNAs have predicted binding sites in the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) viral RNA genome, little experimental validation has been done. We first identified 492 miRNAs that have binding site(s) on the spike (S) viral RNA by a bioinformatics prediction. We then validated the selected 39 miRNAs by examining S-protein levels after coexpressing the S-protein and a miRNA into the cells. Seven miRNAs were found to reduce the S-protein levels by more than 50%. Among them, miR-15a, miR-153, miR-298, miR-508, miR-1909, and miR-3130 also significantly reduced SARS-CoV-2 viral replication. SARS-CoV-2 infection decreased the expression levels of miR-298, miR-497, miR-508, miR-1909, and miR-3130, but had no significant effects on miR-15a and miR-153 levels. Intriguingly, the targeting sequences of these miRNAs on the S viral RNA showed sequence conservation among the variants of concern. Our results suggest that these miRNAs elicit effective antiviral defense against SARS-CoV-2 by modulating S-protein expression and are likely targeting all the variants. Thus, the data signify the therapeutic potential of miRNA-based therapy for SARS-CoV-2 infections.NEW & NOTEWORTHY MicroRNAs can impact viruses either by directly interacting with the virus genome or by modulating host factors. We identified that cellular miRNAs regulate effective antiviral defense against SARS-CoV-2 via modulating spike protein expression, which may offer a potential candidate for antiviral therapy.

Silencing of SARS-CoV Spike Gene by Small Interfering RNA in HEK 293T Cells

Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference.

Inhibition of Genes Expression of SARS Coronavirus by Synthetic Small Interfering RNAs

Synthetic Peptides Outside the Spike Protein Heptad Repeat Regions As Potent Inhibitors of Sars-Associated Coronavirus

Inhibition Of Sars-Cov Gene Expression By Adenovirus-Delivered Small Hairpin Rna

Small Interfering Rna Inhibits Sars-Cov Nucleocapsid Gene Expression in Cultured Cells and Mouse Muscles

Inhibition of Porcine Hemagglutinating Encephalomyelitis Virus (HEV) Replication by Sirna Targeting the Spike Glycoprotein (S) Gene in N2a Cells

Inhibition of Severe Acute Respiratory Syndrome Virus Replication by Small Interfering RNAs in Mammalian Cells

Prophylactic and Therapeutic Effects of Small Interfering RNA Targeting SARS-coronavirus.

In Vitro Inhibition of Porcine Hemagglutinating Encephalomyelitis Virus Replication with Sirnas Targeting the Spike Glycoprotein and Replicase Polyprotein Genes

siRNA designs to the crucial proteins of SARS coronavirus

Properties of Isonucleotide-Incorporated Oligodeoxynucleotides and Inhibition of the Expression of Spike Protein of Sars-Cov

siRNA targeting the Leader sequence of SARS-CoV inhibits virus replication

Inhibiting Severe Acute Respiratory Syndrome-Associated Coronavirus by Small Interfering Rna

Inhibition of Gene Expression Directed by Small Interfering Rnas in Infectious Bronchitis Virus

Cellular Micrornas Target SARS-CoV-2 Spike Protein and Restrict Viral Replication

SARS-CoV-2 Spike Produced in Insect Cells Elicits High Neutralization Titres in Non-Human Primates.

Inhibition of SARS-CoV Infection in Vero-E6 Cells by Sirnas

Engineered External Guide Sequences Effectively Block Viral Gene Expression and Replication in Cultured Cells

Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration

A coronavirus-mimic mesoporous silica nanosystem enables efficient targeted delivery of siRNA for anti-SARS-CoV‐2